Health Trials

About this trial

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Eligibility criteria

Qualifiers

Initial treatment with platinum-containing or taxane-based CTX (regardless of the the length of the CTX cycle)

Senological, gynecological or internistic tumors

Phantogeusia (on average ≥4 NRS)

Willingness to participate in the study and written informed consent

Disqualifiers

Severe stomatitis

Dysgeusia before the CTX based on neurological diseases, diabetes, or the ingestion of drugs with taste disorders as side effects

Leucopenia/neutropenia

Intake of anticoagulants

Trial design

Treatments tested in this trial

  • Hypoglossal acupuncture
  • Sham acupuncture
  • Dietary recommendations

Treatment groups

75 Participants
are divided into 3 treatment groups

Locations

3
Department of Gynecology & Gynecologic Oncology, Evang. Kliniken Essen-Mitte45136, EssenNorth Rhine-Westphalia, Germany
Universitätsklinikum Mannheim, Internistische Onkologie68167, Mannheim Germany
Robert Bosch Krankenhaus Stuttgart70376, Stuttgart Germany

Sponsors and collaborators

Universität Duisburg-Essen

Lead sponsor

Source ClinicalTrials.gov